Marilyn A Huestis Selected Research

Biomarkers (Surrogate Marker)

1/2023	Associations between prenatal and postnatal substance exposure and salivary C-reactive protein in early childhood.
7/2018	Additive drug-specific and sex-specific risks associated with co-use of marijuana and tobacco during pregnancy: Evidence from 3 recent developmental cohorts (2003-2015).
12/2010	Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
6/2010	Nicotine and metabolites in meconium as evidence of maternal cigarette smoking during pregnancy and predictors of neonatal growth deficits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marilyn A Huestis Research Topics

Disease

26	Substance-Related Disorders (Drug Abuse) 01/2023 - 10/2003
10	Neonatal Abstinence Syndrome 01/2020 - 09/2004
9	Opioid-Related Disorders (Opiate Addiction) 01/2020 - 12/2007
7	Marijuana Abuse (Cannabis Abuse) 01/2018 - 10/2011
5	Substance Withdrawal Syndrome (Withdrawal Symptoms) 09/2023 - 10/2011
5	Birth Weight (Birth Weights) 07/2018 - 09/2004
4	Schizophrenia (Dementia Praecox) 09/2013 - 02/2011
3	Overweight 01/2020 - 02/2011
2	Respiratory Insufficiency (Respiratory Failure) 02/2024 - 12/2022
2	Confusion (Bewilderment) 01/2022 - 01/2020
2	Tachycardia (Tachyarrhythmias) 01/2022 - 11/2007
2	Drug Overdose 01/2021 - 12/2020
2	Pain (Aches) 01/2021 - 01/2016
2	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2020 - 09/2004
2	Fatigue 01/2020 - 03/2016
2	Hypotension (Low Blood Pressure) 01/2019 - 03/2006
2	Mental Disorders (Mental Disorder) 11/2018 - 05/2012
2	Weight Loss (Weight Reduction) 11/2014 - 02/2011
1	Paranoid Disorders (Paranoia) 02/2024
1	Nausea 02/2024
1	Vomiting 02/2024
1	Inflammation (Inflammations) 01/2023
1	Vasculitis (Vasculitides) 11/2022
1	Mood Disorders (Mood Disorder) 01/2021
1	Stroke (Strokes) 08/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Spontaneous Abortion (Miscarriage) 01/2020
1	Psychomotor Disorders 01/2020
1	Wounds and Injuries (Trauma) 01/2019
1	Epileptic Syndromes 01/2019
1	Catalepsy 12/2018
1	Hypothermia 12/2018
1	Alcoholism (Alcohol Abuse) 11/2018
1	Marijuana Use 07/2018
1	Pruritus (Itching) 01/2016
1	Hyponatremia 01/2016
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2016
1	Neuralgia (Stump Neuralgia) 01/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2015
1	Seizures (Absence Seizure) 03/2015
1	Neoplasms (Cancer) 11/2014
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 06/2014
1	Cognitive Dysfunction 01/2014
1	Tobacco Use Disorder (Nicotine Dependence) 01/2014

Drug/Important Bio-Agent (IBA)

16	Dronabinol (THC)FDA LinkGeneric 02/2024 - 11/2004
10	Cocaine (Cocaine HCl)IBA 01/2023 - 11/2005
10	Methadone (Dolophine)FDA LinkGeneric 01/2020 - 09/2004
9	Opioid Analgesics (Opioids)IBA 01/2021 - 10/2004
8	Buprenorphine (Subutex)FDA LinkGeneric 01/2020 - 10/2004
8	CannabinoidsIBA 01/2020 - 06/2010
7	Opiate AlkaloidsIBA 01/2023 - 10/2003
7	RimonabantIBA 01/2014 - 03/2006
6	Morphine (MS Contin)FDA LinkGeneric 02/2024 - 10/2003
6	nasIBA 06/2012 - 09/2004
5	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2016 - 09/2006
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2010
4	CannabidiolIBA 01/2018 - 01/2011
4	Codeine (Codeine Phosphate)FDA LinkGeneric 01/2010 - 10/2003
3	mitragynineIBA 02/2024 - 01/2021
3	EndocannabinoidsIBA 09/2023 - 02/2011
3	Nicotine FDA Link 01/2023 - 02/2011
3	nabiximols (Sativex)IBA 01/2018 - 01/2011
3	Methamphetamine (Desoxyn)FDA LinkGeneric 06/2014 - 09/2012
2	Opioid Receptors (Opioid Receptor)IBA 02/2024 - 12/2022
2	6-O-monoacetylmorphineIBA 02/2010 - 01/2010
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2023
1	AmphetaminesIBA 01/2023
1	C-Reactive ProteinIBA 01/2023
1	ArrestinIBA 12/2022
1	Levamisole (Decaris)FDA Link 11/2022
1	Lysergic Acid Diethylamide (LSD)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Therapeutic UsesIBA 01/2021
1	Tryptamines (Triptans)IBA 12/2020
1	SolventsIBA 08/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	GoldIBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Claudin-5IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	1-(5-fluoropentyl)-3-(1-naphthoyl)indoleIBA 12/2018
1	SmokeIBA 11/2018
1	anandamide (arachidonylethanolamide)IBA 11/2016
1	EnzymesIBA 11/2016
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 11/2016
1	Naloxone Drug Combination Buprenorphine FDA Link 10/2016
1	11- nor- delta(9)- tetrahydrocannabinol- 9- carboxylic acidIBA 01/2016
1	N- (adamantan- 1- yl)- 1- (5- fluoropentyl)- 1H- indole- 3- carboxamideIBA 03/2015
1	Analgesics (Analgesic Drugs)IBA 11/2014
1	Hypnotics and Sedatives (Sedatives)IBA 05/2014
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2014
1	(1- pentyl- 1H- indol- 3- yl)(2,2,3,3- tetramethylcyclopropyl)methanoneIBA 11/2013
1	XLR-11IBA 11/2013

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 01/2019 - 01/2008
2	Therapeutics 07/2016 - 08/2015
2	Prenatal Care (Care, Prenatal) 04/2013 - 05/2012
1	Oral Administration 01/2019
1	Secondary Prevention 07/2016
1	Pain Management 03/2016